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BACKGROUND: The Timed Up and Go Test (TUG Test) has previously been described as
a reliable tool to evaluate objective functional impairment in patients with degenerative
disc disease.
OBJECTIVE: The aim of this study was to assess the minimum clinically important
difference (MCID) of the TUG Test.
METHODS: The TUG Test (measured in seconds) was correlated with validated patient-
reported outcomemeasures (PROs) of pain intensity (Visual Analog Scale for back and leg
pain), functional impairment (Oswestry Disability Index, Roland Morris Disability Index),
and health-related quality of life measures (Short Form-12 and EuroQol 5D). Three estab-
lished methods were used to establish anchor-based MCID values using responders of
the following PROs (Visual Analog Scale back and leg pain, Oswestry Disability Index,
Roland Morris Disability Index, EuroQol 5D index, and Short Form-12 Physical Component
Summary) as anchors: (1) average change, (2) minimumdetectable change, and (3) change
difference approach.
RESULTS: One hundred patients with a mean ± SD age of 56.2 ± 16.1 years, 57 (57%) male,
45 patients undergoing microdiscectomy, 35 undergoing lumbar decompression, and 20
undergoing fusion surgery were studied. The 3 MCID computation methods revealed a
rangeofMCIDvalues according to thePROused from0.9 s (OswestryDisability Indexbased
on the change difference approach) to 6.0 s (EuroQol 5D index based on the minimum
detectable change approach), with a mean MCID of 3.4 s for all measured PROs.
CONCLUSION: TheMCID for the TUGTest time is highly variable dependingon the compu-
tation technique used. The average TUG Test MCID was 3.4 s using all 3 methods and all
anchors.
KEY WORDS: Degenerative disc disease, Low back pain, Lumbar spine surgery, MCID, Objective outcome
measurement, Postoperative outcome, Timed Up and Go Test
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P atient-reported outcome measures(PROs) have become the standardmeasure of treatment effectiveness in
ABBREVIATIONS: D3, day 3; DDD, degenerative
disc disease; EQ5D, EuroQol 5D; FU, follow-up;
HRQoL, health-related quality of life; MCID,
minimum clinically important difference; ODI,
Oswestry Disability Index; OFI, objective functional
impairment; PCS, Physical Component Summary;
PRO, patient-reported outcome measure; RMDI,
Roland-Morris Disability Index; SF-12, Short Form 12;
TUG Test, Time Up and Go Test; VAS, Visual Analog
Scale
patients undergoing spine surgery for degener-
ative disc disease (DDD).1 Outcome assessment
in lumbar DDD does not only assist in
monitoring safety and treatment efficacy of
any surgical or nonsurgical treatment, but is
also useful for comparing different treatment
strategies.2 One of the major drawbacks of
well-established PROs (eg, Oswestry Disability
Index [ODI] and Roland-Morris Disability
Index [RMDI] for functional impairment and
Short Form 36, Short Form 12 [SF-12], and
EuroQol 5D [EQ5D] for health-related quality
of life [HRQoL]) is their limited compara-
bility. Patients may rate their subjective pain
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or functional disability differently for reasons of educa-
tional, cultural, and motivational interindividual differences.3
Altogether, there is a dearth of objective, or at least less subjective,
measures of functional disability to aid the process of clinical
decision making in lumbar DDD. Currently, the only existing
objective clinical outcome measures are the measurement of
range of movement (eg, with a goniometer), the measurement
of absolute muscle strength (eg, with a newton meter), or the
measurement of walking speed and distance.3,4 New objective
outcome measures have been tested using an advanced tracking
technology based on global positioning systems. Thus far, none
of these measurements have been adopted into daily clinical
routine.5,6
We recently presented the validation of a simple test, the Timed
Up and Go Test (TUG Test), as a measurement tool of objective
functional impairment (OFI) with an excellent intra- and inter-
rater reliability.4,7 The validity of the TUG Test was demon-
strated with good correlation with the Visual Analog Scale (VAS)
back and leg pain and functional impairment indexes (RMDI and
ODI), as well as with HRQoL. The upper limit of “normal” was
determined as 11.5 s, and the correspondingOFI could be catego-
rized as mild, moderate, and severe OFI according to age, sex, and
TUG Test time performance.7
Although all established PROs deliver specific numeric values
of pain intensity, functional impairment, and HRQoL, the scores
do not directly translate into clinically meaningful improvement.1
Thus, the concept of theminimum clinically important difference
(MCID) was established and later introduced as a critical
threshold to define/determine treatment effectiveness.1,8 The
original conceptualization of MCID was an implicit ratio to
weigh benefits and risks of treatment.9 Currently, MCID research
mainly focuses on the benefit side of this ratio and most
commonly considers MCID to be “the smallest change that is
important to patients.”10 So far, several studies have reported
a range of different MCIDs for established PROs in different
patient populations with various spinal pathologies.1
The aim of this study was to assess the MCID of the TUG Test
as a measure of functional impairment for patients undergoing
surgery for lumbar DDD.
METHODS
Patients were prospectively enrolled at the Departments of Neuro-
surgery of the University Hospital Geneva and the Cantonal Hospital
St. Gallen in Switzerland between September 2013 and April 2015.
Patients were scheduled for lumbar spine surgery for the following
diagnoses: (1) lumbar disc herniation, (2) lumbar spinal stenosis, and
(3) lumbar DDD with or without instability requiring lumbar fusion
(transforaminal lumbar interbody fusion, posterior lumbar interbody
fusion, or extreme lateral interbody fusion). Exclusion criteria were age
younger than 18 years, pregnancy, severe neurological deficits, or other
medical reasons interfering with the patients’ ability to walk and perform
the TUG Test (eg, Parkinson disease, wheelchair user, severe congestive
heart failure). Patient demographic data (age, sex, size, weight, body
mass index, and working status) as well as clinical data (British Medical
Research Council muscle strength of index muscles of the lower extrem-
ities, smoking status, and previous surgery) were obtained preoperatively.
VAS back and leg pain scores, RMDI and ODI questionnaires, and the
SF-12 (including both physical and mental component summary [PCS
andMCS] scores), and EQ5D questionnaires were recorded, and a single
TUG Test was performed at baseline, day 3 (D3), and at week 6 (W6) of
follow-up (FU). There were 4 qualified raters who performed the TUG
Test, including 3 residents in advanced training and 1 board-certified
staff neurosurgeon.
Ethics Approval
The study was approved by the Institutional Review Board of the
University of Geneva (14-079) and the Ethics Committee St. Gallen
(14/049). Written informed consent was obtained from every study
participant.
Statistical Analysis
TUG Test times and various subjective outcome measures at baseline,
D3, and W6 were compared using t tests. Previously established PROs,
including pain intensity (VAS back and leg pain scores), functional
impairment (ODI and RMDI), and HRQoL (EQ5D index and SF-12
PCS score) were used as anchors according to the method of Parker et al.1
Responder status to surgical treatment was defined at the W6 FU using
previously published MCID values for an ODI of 12.8, RMDI of 5.0,
PCS of 4.9, EQ5D index of 0.359, VAS leg pain score of 1.6, and VAS
back pain score of 1.2 to generate a binary responder and nonresponder
variable.8,10-13 Three previously published anchor-based approaches were
used to assess theMCID after lumbar spine surgery.1 According to Parker
et al,1 we computed the MCID based on specified definitions using the
previously mentioned anchors: Method (1) The average change approach
defines the MCID as the average change in the study cohort defined
as responders. Method (2) The minimum detectable change approach
defines the MCID as the smallest change that can be considered above
the measurement error. TheMCID is thus equal to the upper value of the
95% confidence interval for the average change score seen in the study
cohort defined as nonresponders. Method (3) The change difference
approach defines the MCID as the difference in the average change score
for responders and nonresponders. These methods produce a multitude
of MCIDs, and although there is no consensus on the optimal method,
we built the average of all MCIDs to determine the clinically used
MCID.
Data were analyzed using Stata version 14.0 (StataCorp, College
Station, Texas). Statistical significance was accepted at P < .05.
RESULTS
The patient cohort included 100 patients (43 female patients,
43.0%) with a mean ± SD age of 56.2 ± 16.1 years. Before
hospitalization, 44 patients (44.0%) worked full or part time,
16 patients (16.0%) were not working, 3 patients (3.0%) were
disabled, and 37 patients (37.0%) were retired. Forty-five patients
(45.0%) underwent microdiscectomy for lumbar disc herni-
ation or recurrent lumbar disc herniation, 35 patients (35.0%)
underwent a uni- or bilateral decompression for lumbar spinal
stenosis, and 20 patients (20.0%) underwent a lumbar fusion
procedure. At the W6 FU, statistically significant improvement
(P < .001) was observed for the following PROs assessed: VAS
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TABLE 1. Pre- and Postoperative Subjective and Objective Measures at Baseline, 3 Days, and 6Weeksa ,b
Measure Preoperative D3 P W6 FU P D3 vsW6
TUG Test time (seconds) 10.1 (5.0) 9.4 (4.5) .3198 6.6 (3.2) <.0001 <0.0001
VAS back pain score 3.8 (1.0) 2.1 (1.8) <.0001 1.4 (1.7) <.0001 0.0031
VAS leg pain score 5.5 (2.8) 0.9 (1.4) <.0001 1.0 (1.7) <.0001 0.7484
ODI 46 (18) 32 (18) <.0001 21 (17) <.0001 <0.0001
RMDI 12 (5) 9 (6) .0014 5 (5) <.0001 <0.0001
EQ5D index 0.440 (0.218) 0.674 (0.202) <.0001 0.744 (0.187) <.0001 0.0008
SF-12 PCS 31.3 (7.7) 35.0 (6.9) .0008 40.5 (8.3) <.0001 <0.0001
SF-12 MCS 41.9 (9.7) 42.5 (10.7) .5177 48.1 (10.3) <.0001 0.0003
aD3, day 3; EQ5D, EuroQol-5D; FU, follow-up; MCS, Mental Component Summary; ODI, Oswestry Disability Index; PCS, Physical Component Summary; RMDI,
Roland-Morris Disability Index; SF-12, Short Form 12; TUG Test, Timed Up and Go Test; VAS, Visual Analog Scale; W6, week 6.
bThe statistical analysis is in comparison with the preoperative baseline measures. The last row compares D3 and W6 follow-up. Values shown are mean± SD.
back and leg pain scores (mean improvement, −2.5 ± 2.9
and −4.5 ± 3.3, respectively), ODI (−24.6 ± 17.4), RMDI
(−6.4± 6.1), EQ5D index (+0.304± 0.249), SF-12 PCS (+9.2
± 9.1), and SF-12 MCS (+6.2 ± 9.6). Also, the TUG Test
time revealed a significant mean improvement (−3.5 ± 4.6 s,
P < .001).
Subjective and objective measures (mean ± SD values) are
shown in Table 1. All subjective outcome measures except SF-12
MCS significantly improved at D3 after the surgery. The mean
TUG Test time did not improve significantly in the early postop-
erative period (10.1 ± 5.0 s preoperatively compared with 9.4 ±
4.5 s at D3 [P = .32]). FromD3 to theW6 FU, all subjective and
objective outcome measures significantly improved (P < .003)
except VAS leg pain score, which already had improved to its
maximum at D3 (Table 1).
Sixty-one patients (61%) and 82 patients (82%) were re-
sponders according to the MCID for VAS back and leg pain,
respectively. Seventy-three patients (73%) and 61 patients (61%)
were responders according to theMCID for the ODI and RMDI,
respectively. Forty-three patients (43%), 29 patients (29%), and
38 patients (38%)were responders according to theMCID for the
EQ5D index, the SF-12 PCS, and the SF-12 MCS, respectively.
Using VAS back pain score as an anchor, the MCID threshold for
the TUG Test time ranged from 1.3 to 5.3 s depending on the
computation method (Table 2). Using the VAS leg pain score as
an anchor, the MCID threshold for the TUG Test time ranged
from 1.3 to 4.8 s depending on the computation method. Using
the ODI as an anchor, the MCID threshold for the TUG Test
ranged from 0.9 to 4.8 s depending on the computation method.
Using the RMDI as an anchor, the MCID threshold for the TUG
Test time ranged from 1.5 to 5.1 s depending on the compu-
tation method. Using the EQ5D index as an anchor, the MCID
threshold ranged from 1.7 to 6.0 s depending on the compu-
tation method. Finally, using the SF-12 PCS as an anchor, the
MCID threshold for the TUG Test time ranged from 2.0 to
3.4 s depending on the computation method. For all anchors
except the SF-12 PCS, the largest threshold was always derived
from the minimum detectable change approach, whereas the
smallest threshold was always derived from the change difference
approach. The mean MCID for all methods and for all measured
PROs was 3.4 s.
DISCUSSION
This study aimed to determine the MCID of the TUG Test
time as a measure of OFI in lumbar DDD. An average of
TABLE 2. ThreeMCIDComputationMethodsUsing 6DifferentAnchors IncludingPain Intensity (VASBack and LegPain Scores),
Functional Impairment (ODI and RMDI), and Health-Related Quality of Life (EQ5D Index, SF-12 PCS)a
Anchor-Based Approach Back Pain Leg Pain ODI RMDI EQ5D Index SF-12 PCS Overall
Method (1) Average change (secs) 4.0 3.8 3.8 4.1 4.5 2.0 3.7
Method (2) MDC (95% CI) (secs) 5.3 4.8 4.8 5.1 6.0 3.4 4.9
Method (3) Change difference secs 1.3 1.3 0.9 1.5 1.7 2.1 1.5
Overall secs 3.5 3.3 3.2 3.6 4.1 2.5 3.4
aCI, confidence interval; EQ5D, EuroQol-5D; HRQoL, health-related quality of life; MCID, minimum clinically important difference; MCS, Mental Component
Summary; MDC, minimum detectable change; ODI, Oswestry Disability Index; PCS, Physical Component Summary; RMDI, Roland-Morris Disability Index, SF-12,
Short Form 12; VAS, Visual Analog Scale.
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TABLE 3. Case PresentationsMentioned in the Discussion Sectiona
Preoperative D3 FU W6 FU
Patient 1 (44 y, female,
microdiscectomy L4-5)
VAS back pain score 6; VAS leg
pain score, 6; RMDI, 19; ODI,
52%; SF-12 PCS, 21.2; TUG Test,
12.53 s (z score), 2.75 (t score),
127.50, mild OFI
VAS back pain score, 0; VAS leg
pain score, 0; RMDI, 2; ODI,
6%; SF-12 PCS, 42.4; TUG Test,
7.53 s (z score, 0.64; t score,
106.36; no OFI)
VAS back pain score, 0; VAS leg
pain score, 0; RMDI, 2; ODI,
6%; SF-12 PCS, 42.4; TUG Test,
4.54 s (z score,−0.63; t score,
93.69; no OFI)
Patient 2 (70 y, male,
decompression L3-4
with undercutting)
VAS back pain score, 2; VAS leg
pain score, 4; RMDI, 10; ODI,
44%; SF-12 PCS, 33.9; TUG Test,
18.36 s (z score, 5.22; t score,
152.25; moderate OFI)
VAS back pain score, 2; VAS leg
pain score, 0; RMDI, 17; ODI,
76%; SF-12 PCS, 35.2; TUG Test,
30 s (z score, 10.16; t score,
201.57; severe OFI)
VAS back pain score, 1; VAS leg
pain score, 1; RMDI, 13; ODI,
50%; SF-12 PCS, 35.2; TUG Test,
7.83 s (z score, 0.76; t score,
107.63; no OFI)
aD3, day 3; FU, follow-up; ODI, Oswestry Disability Index; OFI, objective functional impairment; PCS, Physical Component Summary; RMDI, Roland-Morris Disability
Index, SF-12, Short Form 12; TUG Test, Timed Up and Go Test; VAS, Visual Analog Scale; W6, week 6.
3 different computation methods, based on the MCIDs of estab-
lished PROs including pain intensity, functional impairment,
and HRQoL as anchors, was used. This approach revealed an
average MCID for the TUG Test time of 3.4 s. In other words,
an improvement of 3.4 s translates into clinically meaningful
improvement in function in patients with lumbar DDD. The
MCID is an important concept, as the absolute numeric results
of PROs assessing pain intensity, functional impairment, and
HRQoL may not correlate well with the patient’s perception of
clinical improvement. TheMCID reflects the threshold of a clini-
cally meaningful improvement (or worsening) for the patient.
The change in t score of the TUG Test result in responders was −
31.00, with an SD of 21.98 and a range of − 87.50 to −14.41,
indicating a significant improvement in function in patients who
achieve an improvement by 3.4 s. The change in t score in nonre-
sponders was −5.19, with an SD of 8.77 and a range of − 14.32
to 47.07. We believe that the obtained MCID values confirm our
personal experience from patient FU in clinics.
Two clinical examples from our collected data are presented to
demonstrate the clinical use of the TUG Test and OFI (Table 3).
Case 1
A 44-year-old female patient is scheduled for a lumbar
microdiscectomy at L4-5. The patient’s clinical and neurological
examination does not reveal a motor deficit, but does reveal signif-
icant disability in terms of VAS back and leg pain (both 6/10)
scores and remarkable impairment in function and HRQoL. Her
preoperative TUG Test time is 12.53 s (z score of 2.75 and t score
of 127.50). Thus, she is classified as having mild OFI.7 Surgery is
uneventful, and on D3, her D3 TUG Test time is 7.53 s, which
is 5 s faster than preoperatively. At D3, this patient can already be
considered a responder to treatment.
Case 2
A 70-year-old male patient is scheduled to undergo selective
decompression with undercutting at L3-4 for degenerative
lumbar spinal stenosis. He presents without motor deficit, but
with classic neurogenic claudication. His preoperative TUG Test
time is 18.36 s (z score of 5.22 and t score of 152.25), which
classifies him as having moderate OFI.7 Subsequent surgery is
performed without complications, but on D3, his TUG Test
time is 30 s. At this early point in time/FU, the patient clearly
is a nonresponder, if not a negative responder, in terms of TUG
Test metrics. In addition, the PROs confirm increased disability
(Table 3). We saw the patient again at the W6 FU in our
outpatient clinic. His W6 TUG Test time was 7.83 s (z score
of 0.76 and t score of 107.63), which is an improvement of
10.53 s compared with baseline. Using the MCID of 3.4 s, this
patient can now be considered a treatment responder in terms
of TUG Test metrics at W6, although the PROs still show some
impairment.
Even though the mean MCID is 3.4 s, we noticed a large
range of 0.9 to 6.0 s depending on the respective subjective
scale and computation method used (Table 2). This is in line
with the literature, which reports a large variability of reported
MCIDs due to a variety of methods used to calculate MCIDs.
This range of values stems from the fact that there is no
gold standard measure of change, and thus many different
theories exist on how to best estimate and measure the concept
of change. Currently, there is no consensus on which is the
superior method.1 The previously mentioned range suggests
that the true value of the change lies somewhere between 0.9
and 6 s, but the greatest likelihood is that it should lie at
∼3.4 s. Given this range, it is feasible that, on further research,
the MCID may change as estimates improve in accuracy or a
single method becomes accepted. The application of confidence
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intervals to the range of MCIDs presented here is not appropriate
because the many MCIDs generated do not represent sampling
distributions.
We would like to take the opportunity to emphasize that
that the anchors used (gold standard) were based on PROs, and
PROs measure different dimensions than the objective outcome
measures used in this study. Other methods, such as using the
SE of measurement, may be useful to validate the previously
mentioned MCIDs, and further work on this aspect is ongoing.
TUG Test time measurements after surgery is an important
issue that should be mentioned. The variation of TUG 3 days
after surgery was quite large for the current sample of 100 patients:
the mean change in TUG was −0.66 s, and the range was −20.3
to 18.5 s. Applying the MCID of 3.4 s, only 14% of patients
would be considered to be responders to surgery at D3 on the
objective scale using the TUG Test. The responder rate early
after surgery may be higher when subjective scales are used. Our
current data show responder rates ranging from 8% (SF-12 PCS),
34% (RMDI), 49% (ODI), 54% (VAS back pain score) up to
79% (VAS leg pain score) as determined by the MCID of each
scale, respectively. We concluded that on D3, patients clearly
experience relief from preoperative irradiating pain and/or are
already experiencing some extent of neurological recovery. The
psychological effect of having undergone successful surgery may
further factor into the patient’s subjective perception of pain. The
TUG Test here demonstrates what physicians and health care
workers experience in the daily care of patients after lumbar spine
surgery: despite feeling better, walking ability andmobility are still
greatly constrained. Thus, a clinically meaningful change in the
TUG Test metric is rather difficult to obtain in the early postop-
erative period and should be reserved for medium- and long-term
FU. At the W6 FU assessment, the mean change in TUG Test
time was −3.5 s, with a range of −20.6 to 11.1 s. According to
the average MCID of 3.4 s, 38% of the current sample would
be considered treatment responders on the TUG Test, whereas
62% of patients would be classified as nonresponders. Comparing
this with the subjective scales, on which W6 FU responder rates
ranged from 29% (SF-12 PCS) to 82% (VAS leg pain score), may
indicate that recovery of measurable function is still in process
at W6. Long-term data will shed more light on the dynamics of
recovery of patients with DDD on the TUG Test metric.
CONCLUSION
TheMCID for the TUGTest time is highly variable depending
on the computation technique used. Using all 3 methods and
all anchors, the suggested TUG MCID to be used in future
studies is 3.4 s. The obtained MCID values confirm our personal
experience of clinically meaningful recovery from patient FU in
clinical daily routine.
Disclosures
Expenditures (questionnaires, study nurse) were financed by the Department
of Neurosurgery, Cantonal Hospital St. Gallen. The authors have no personal,
financial, or institutional interest in any of the drugs, materials, or devices
described in this article.
REFERENCES
1. Parker SL, Godil SS, Shau DN, Mendenhall SK, McGirt MJ. Assessment of the
minimum clinically important difference in pain, disability, and quality of life after
anterior cervical discectomy and fusion: clinical article. J Neurosurg Spine. 2013;18
(2):154-160.
2. Vavken P, Ganal-Antonio AK, Shen FH, Chapman JR, Samartzis D.
Fundamentals of clinical outcomes assessment for spinal disorders: study designs,
methodologies, and analyses. Glob Spine J. 2015;5(2):156-164.
3. Gautschi OP, Corniola MV, Schaller K, Smoll NR, Stienen MN. The need
for an objective outcome measurement in spine surgery–the timed-up-and-go test.
Spine J. 2014;14(10):2521-2522.
4. Gautschi OP, Corniola MV, Joswig H, et al. The timed up and go test for lumbar
degenerative disc disease. J Clin Neurosci. 2015;22(12):1943-1948.
5. Barzilay Y, Noam S, Meir L, et al. Assessing the outcomes of spine surgery using
global positioning systems. Spine (Phila Pa 1976). 2011;36(4):E263-E267.
6. Mobbs RJ, Phan K, Maharaj M, Rao PJ. Physical activity measured with
accelerometer and self-rated disability in lumbar spine surgery: a prospective study.
Glob Spine J. 2015 [Epub ahead of print].
7. Gautschi OP, Smoll NR, Corniola MV, et al. Validity and reliability of a
measurement of objective functional impairment in lumbar degenerative disc
disease: the timed-up-and-go (tug) test. Neurosurgery. 2015 [Epub ahead of print].
8. Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon
LY. Minimum clinically important difference in lumbar spine surgery patients:
a choice of methods using the Oswestry Disability Index, Medical Outcomes
Study questionnaire Short Form 36, and pain scales. Spine J. 2008;8(6):
968-974.
9. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining
the minimal clinically important difference. Control Clin Trials. 1989;10(4):
407-415.
10. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of
the Roland-Morris back pain questionnaire: part 1. Phys Ther. 1998;78(11): 1186-
1196.
11. Ostelo RW, Deyo RA, Stratford P, et al. Interpreting change scores for pain
and functional status in low back pain: towards international consensus regarding
minimal important change. Spine (Phila Pa 1976). 2008;33(1):90-94.
12. Parker SL, Mendenhall SK, Shau D, et al. Determination of minimum
clinically important difference in pain, disability, and quality of life after
extension of fusion for adjacent-segment disease. J Neurosurg Spine. 2012;16 (1):
61-67.
13. Parker SL, Mendenhall SK, Shau DN, et al. Minimum clinically important
difference in pain, disability, and quality of life after neural decompression and
fusion for same-level recurrent lumbar stenosis: understanding clinical versus statis-
tical significance. J Neurosurg Spine. 2012;16(5):471-478.
Acknowledgments
The authors thank Cornelia Lüthi (a study nurse in the Department of
Surgery, Cantonal Hospital St. Gallen), Dario Jucker (medical student at Zurich
University), and Ivan Chau (Department of Neurosurgery, Cantonal Hospital St.
Gallen) for their important contributions in data collection.
NEUROSURGERY VOLUME 00 | NUMBER 0 | 2017 | 5
